Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let’s see what we get when Q results are announced. I hope we start to see some sort of clarity.
I found a few on my watch list that were all over the place.
Explain
It’s significantly undervalued and the only ones that can change that is management. I have been told many times that they I tend to communicate more as soon as Q results are out, so we shall see.
I see the 2 clowns are back.
At the latest month end, but from conversations with company I believe they hope to issue it earlier than that. I believe Gedi posted something on this.
From my take business is doing really well at the moment, and got to think they are making some nice interest on that pile of cash. Q results should be quite telling, just hope either RXMD or NXPL hold a conference call this time.
It does amaze me that being so close to what I expect to be record earnings people would sell any shares at the current low price.
Over half our very low market cap is covered by cash on hand.
It really would not take a lot of good news to propel share price much higher. The share price has been so over sold on very low volume that any news and pressure to the buy side and we move up very quickly.
I believe your conversations with company have been similar to mine, and I am hoping to see news materialize soon.
Yes and this is the high profit side of the business.
And it appears from what we know the business is stronger than ever.
Yes and the hangover that it’s been quiet because they want to grab cheap shares. I have spoken to company and I know several others have.
Been told several times this is not the case like others have and that from Q results we should start to hear more from company.
I am hoping that either RXMD or more than likely NXPL will hold a Q conference call this time.
They never forgot, see PR issued on the 15th;
“The Company will be presenting its plan to the Nasdaq Hearings Panel regarding equity compliance.”
A few on the board would say no, but if you look at the company it has no debt, $7 to $8 million in the bank and increasing revenue now well over $40 million a year, oh and increasing profit margins as its higher profit areas are increasing.
Big negative has been management silence, which my understanding is will change when Q results are released anytime from end of next week to month end.
You would think there is way more money to be made on the upside than downside.
Price at moment is pretty much ridiculous but being fuelled by now volume.
Now what would happen if company announced it intended to uplist, price would shoot through the roof.
I know we are just around the corner from being updated, but this share price and these little sells to knock it down, suck.
Current price is ridiculous, reason why I have continued to add.
Thanks Gedi, appreciate you continuing dialogue with the company as I have done several times.
I totally agree management need to communicate with shareholders, but bashing the fundamentals of the company when clearly that side has improved significantly.
Patent is for the current mask in front of the FDA
They must be doing something right, their cash balance sheet added $300,000.
Total revenues increased by approximately $2.2 million, or 22%, to approximately $12.4 million during the three months ended September 30, 2023, compared to approximately $10.1 million in the prior year period. Sequentially, total revenues increased by approximately 7% over revenue reported for the second quarter of 2023.
? Prescription revenue, net of PBM fees, increased by approximately $1.1 million, or 13%, to approximately $9.9 million during the third quarter of 2023, compared to approximately $8.8 million in the prior year period.
? 340B contract revenue was approximately $2.5 million during the third quarter of 2023, an increase of approximately $1.3 million, compared to approximately $1.2 million in the prior year period. The increase was attributable to an increase in our existing 340B contracts.
? Gross profit margin increased to approximately 31% from approximately 21% reported in the third quarter of 2022.
? Cash balance as of September 30, 2023 was approximately $7.0 million as compared to approximately $6.7 million as of December 31, 2022.
Yes I agree, they can bash the share price which I totally concede is due to the lack of communication from the company, but you really can’t bash the business and it balance sheet, it’s way better than it was a few years back.
Got to think they are earning around $100,000 + a Q in interest alone on the cash they have
It was saddled with debt, which no longer is the case.
Over the past few Q’s we have seen a significant improvement in results, and there would not have been a loss if it was not for accounting rules related to NXPL investment. There was a lot of noise in results due to this which should be gone when company reports next.
From last Q “Gross margins increased significantly to 30% for the quarter ended September 30, 2023, up from 26% reported for the quarter ended September 30, 2022, primarily attributable to the healthcare operations because of the Progressive Care consolidation. Gross profit margin attributable to our healthcare operations were approximately 31%”
Company has certainly been increasing profit margins in its services section which is what I believe we will see continued.
Current market cap is just over 13 million.
Company has around 7-8 million in cash sat in the bank, revenue has been growing and is growing in the higher profit margin revenue streams. Company has no debt.
The biggest issue is not what the company is doing, it’s the lack of clarity from management. There are so many other companies with nothing that are valued way more than RXMD, and it my belief that RXMD is worth way more than a 13 million market cap and at some point if management decide to start talking which my understanding they will as soon as results are out, then the share price should reflect fair value, because it’s not where is should be.
Yes that’s correct, clock starts back where they left off. So if no further info requests made by FDA then should be pretty quick approval after that.
Yes sorry I said that last week, I meant end of March.
Yes we sure are due. I am hoping that NXPL will,hold a Q conference call, which should encompass both companies as a significant amount of NXPL revenue is accounted for by RXMD.
We shall see but it would be a good way of kicking off some communication with shareholders.
No worries my timeline is either late next week or more than likely 2nd week in March we hear something.
Well I added a few more this morning, I have a load already but at this price.
That price would be below cash value on what they have as of today, with somewhere between 7 and 8 million in the bank.
From my discussions with Mike and I know several other have spoken with him, then I believe things will change as soon as Q results are filed in approx 14days.
Sorry I keep putting IMNU I mean IMNM
It was started over 4 weeks ago and it takes 6 weeks or less to complete.
Agree not many have no debt, increasing revenue and $7 to $8 million in the bank.
Most have huge debt and management that pump the hell out of the stock, mind you would be nice to see some commentary from the company once in a while.
Q report around 2 weeks away, I believe things will change around this time.
I think I am right is saying that they could not by shares at the moment anyway as we are so close to Q earnings. After that I believe they could.
Would be good to see some insider buying.
Well IMNU holding just hit $60 million or there abouts.
Thanks RIO, as you point out the company itself is doing just fine, increasing revenue, increasing cash on hand and no debt. I have slowly added when I can a few thousand over the past few months as I do see the current stock price as severely undervalued.
At some point I do believe we are going to hear more from the company as to its plan, and I believe we are close to that time. As I have said before it would be good to see NXPL or RXMD hold a Q conference call, we should find this out pretty soon.
I hope so too.
I am expecting some minor news maybe as early as this coming week or next then much more communication after Q earnings.
You never know we could even see a Q conference call probably from NXPL but they would have to speak about RXMD during the call as it makes us so much of the revenue.
We shall see, all my opinion.
I got the opinion when I spoke with him recently that things were likely to change after Q earnings, and that company would become much more vocal. Just my opinion but that’s what I thought.
Cabin what time you talking to Michael.
I agree lack of communication is what’s hurting this stock, but to say it’s a penny scam is ridiculous for the reasons I have already outlined.